AI startup Points Technology announced that it had obtained two consecutive rounds of financing from Chinese AI firm 4Paradigm and VC company Shenzhen Capital Group.

A popular crypto analyst says Avalanche (AVAX) and other leading layer-1 platforms are starting to flash signs of weakness. Pseudonymous analyst Smart Contracter tells his 205,000 Twitter followers that smart contract platform Avalanche looks bearish after printing consecutive lower highs in its USD and Bitcoin (BTC) pairs. “AVAX still looks very very unhealthy, against BTC […]

The post Avalanche (AVAX) and Several Ethereum Rivals Now Look ‘Very Unhealthy,’ Warns Top Crypto Strategist appeared first on The Daily Hodl.

SANTA ANA, Calif.–(BUSINESS WIRE)–First American Data & Analytics, a division of First American Financial Corporation (NYSE: FAF) and a leading national provider of property and ownership data and advanced analytic solutions, announced today that it has been recognized by HousingWire Magazine as a 2022 HW Tech100™ Real Estate honoree. This is the second year in […]

The post First American Data & Analytics Named One of the Most Innovative Technology Companies in Real Estate by HousingWire Magazine for the Second Year in Row appeared first on Fintech News.

Since September 2021, ADA has posted lower monthly lows against the dollar, with March on track to do the same.

The post Cardano (ADA) set for 7th consecutive monthly red candle, is a bounce due? appeared first on CryptoSlate.

Bugha and Mero dominated the FNCS Chapter 3 Season 1 Finals. Fortnite World Cup 2019 Solo Champion Kyle “Bugha” Giersdorf…

The post Fortnite: Bugha & Mero Three-Peat as FNCS Champions appeared first on Esports News Network | ESTNN.

TOKYO, Mar 7, 2022 - (JCN Newswire) - Fujitsu and the Tokyo Medical and Dental University (TMDU) today announced a new technology that uses AI to discover new causal mechanisms of drug resistance in cancer treatments from clinical data. Leveraging the world's fastest supercomputer "Fugaku,"(1) the new technology enables high-speed calculation of 20,000 variables of data within a single day and allows for the discovery of previously unknown causal relationships relating to drug resistance in cancer cells from 1,000 trillion different possibilities.
Fujitsu and TMDU applied this technology to gene expression level(2) data obtained from cancer cell lines in order to analyze drug resistance(3) against anticancer drugs, and succeeded in extracting a new causal mechanism of a previously unknown gene that suggests a cause of resistance to lung cancer drugs. The new technology is expected to contribute to the acceleration of drug discovery and the realization of cancer therapies individualized for each patient.
The technology was developed under the theme of "elucidation of the cause and diversity of cancer using large-scale data analysis and AI technology," an initiative supported by TMDU, Kyoto University and Fujitsu as part of the supercomputer Fugaku achievement acceleration program(4).

Background

Even if a patient receives a targeted cancer drug(5) therapy, the appearance of drug-resistant cancer cells represents an ongoing threat to full remission. The mechanism for how certain cancers become drug resistant remains unclear, however, and researchers continue to work on new methods of analysis that shed light on how cells that have multiple driver mutations(6) acquire drug resistance. In drug development and clinical trials involving drug repositioning(7), it is important to identify patients for whom drugs are anticipated to have an effect. However, the effectiveness of drugs may differ depending on the organ and the individual and variations in gene expression, and the number of patterns combining expression levels of multiple genes exceeds 1,000 trillion(8). A comprehensive search of all 20,000 genes in the human genome would thus take more than 4,000 years with a conventional computer and finding ways to accelerate the process represents a major challenge.

Newly developed technology

Fujitsu implemented parallel conditional and causal algorithms to maximize computational performance with the supercomputer Fugaku to analyze the human genome within a timeframe needed for practical research. By utilizing Fujitsu's "Wide Learning"(9) AI technology to extract combinations of potential genes relating to the emergence of drug resistance based on statistical information, Fujitsu developed a novel technology that makes it possible to conduct a comprehensive search within a day.

Results

As a result of running data of the Dependency Map (DepMap)(10) portal using this technology on the supercomputer Fugaku, Fujitsu and TMDU were able to search the entire human genome for conditions and causality within a single day and determine the genes that cause resistance to drugs used to treat lung cancer(11).

Comment from Prof. Seiji Ogawa, Graduate School of Medicine, Kyoto University

Promising technologies like Fujitsu's AI technology for scientific discovery ("Wide Learning") may one day contribute to the discovery of biomarkers, which represent an area of growing interest in drug development. The key to the success of new drug development is to identify patients who are expected to benefit from new drugs and conduct clinical trials. If the marker that predicts who will benefit from the drug is known, the cost of clinical trials can significantly be reduced and the probability of success by conducting individual clinical trials can be increased. From this point of view, pharmaceutical manufacturers and others are expected to be very interested in this technology. The fact that it has been implemented using Fugaku has also raised expectations.

Future Plans

Moving forward, Fujitsu and TMDU will conduct a multilayered and comprehensive analysis that combines various data including time axis and location data with the aim of accelerating medical research, including in the field of drug efficacy, as well as to shed light on the causes of cancer.
Fujitsu and TMDU will also collaborate in experimental research in the fields of drug discovery and medicine. TMDU will further utilize the technology developed in this research to promote research on strategies for intractable diseases such as cancer.

In addition to medical care, Fujitsu will utilize the new technology to resolve challenges in a variety of fields, including marketing, system operations and manufacturing.

Acknowledgements
This research was conducted as part of Ministry of Education, Culture, Sports, Science and Technology's Fugaku Achievement Acceleration Program "Understanding the Origin and Diversity of Cancer through Large-scale Data Analysis and Artificial Intelligence Technologies" (JPMXP 1020200102). A part of the research was conducted with the computational resources of supercomputer Fugaku (Issue #: hp 200138, hp 210167).

(1) Supercomputer "Fugaku":
A computer installed at RIKEN as a successor to the supercomputer "K." From June 2020 to November 3, it ranked first in 4 categories in the supercomputer rankings for 4 consecutive years. Full operation started on March 9, 2021.
(2) Gene expression level :
Amount of RNA copied from DNA (the same nucleic acid as DNA synthesized by transcription using some DNA sequences as templates).
(3) Drug resistance :
A phenomenon in which the effect of a drug weakens while the drug is being administered.
(4) Supercomputer Fugaku Achievement Acceleration Program :
Program started in May 2020 by the Ministry of Education, Culture, Sports, Science and Technology with the aim to achieve early results.
(5) Targeted drug :
A drug designed to act only on the molecule (protein, gene, etc.) that is causing the disease.
(6) Driver mutations :
A genetic mutation that directly causes the development or progression of cancer.
(7) Drug repositioning :
The application of existing drugs developed and approved for the treatment of one disease to the treatment of another disease.
(8) More than 1,000 trillion :
Even if the expression level of each gene is restricted to a combination of 50 major genes known to be related to cancer and the expression level of each gene is classified into 2 categories (e.g., "high" or "low" gene expression), the condition number is 2 to the power of 50, which exceeds 1,000 trillion.
(9) Wide Learning :
Official site "Hello, Wide Learning!"
(10) Dependency Map (DepMap) :
Data on the sensitivity and resistance of approximately 4,500 drugs to approximately 600 different cancer cell lines, provided by the American Broad Institute. Mutation information of cancer cell lines and expression data of all genes are included.
(11) Fujitsu and TMDU analyzed gene expression data from DepMap of approximately 300 cancer cell lines, sensitivity and resistance data of Gefitinib (molecularly targeted drug used to treat lung cancer and other cancer types), and comprehensively searched for conditions and mechanisms of cancer cell lines that do not respond to Gefitinib. Fujitsu and TMDU identified conditions under which the expression levels of three transcription factors (genes that control gene transcription (synthesis of RNA)), ZNF516, E2F6, and EMX1, were low. In lung cancer cell lines that meet these conditions, a mechanism triggered by the transcription factors SP7 and PRRX1 was discovered as further potential causes of drug resistance in cancer cells (see reference image).

About Fujitsu

Fujitsu is the leading Japanese information and communication technology (ICT) company offering a full range of technology products, solutions and services. Approximately 126,000 Fujitsu people support customers in more than 100 countries. We use our experience and the power of ICT to shape the future of society with our customers. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$34 billion) for the fiscal year ended March 31, 2021. For more information, please see www.fujitsu.com.
About Tokyo Medical and Dental University

Tokyo Medical and Dental University (TMDU) is Japan's only comprehensive medical university and graduate school, and has provided advanced medical treatment through a fusion of the medical and dental fields and worked to cultivate "professionals with knowledge and humanity." TMDU contributes to human health and the well-being of society by fostering outstanding healthcare professionals with a humane and global outlook.


Copyright 2022 JCN Newswire. All rights reserved. www.jcnnewswire.comFujitsu and the Tokyo Medical and Dental University (TMDU) today announced a new technology that uses AI to discover new causal mechanisms of drug resistance in cancer treatments from clinical data.

Following a week-long winning streak, ANC finally fell on Sunday, as crypto bears finally entered the fray. Despite this, WAVES managed to maintain recent highs, and has now climbed close to 60% in the last week. Anchor protocol (ANC) Following a streak of fresh record highs from Wednesday to Saturday, Sunday saw anchor protocol (ANC) […]

As Bitcoin falls back, the US dollar strengthened following impressive economic statistics that indicated the number of jobs generated in the US, among other related factors, increased far more than projected. Bitcoin – the world’s alpha dog cryptocurrency – slid down into Sunday’s weekly closing, with geopolitical frictions and concomitant macro sluggishness firmly on the…

The post Bitcoin Falls Back To $38,000 As Russia Steps Up Bombardment Of Ukraine appeared first on Bitcoin News Miner.

The post Cardano (ADA), Fantom (FTM) & Solana Price Might Plunge More Than 25% In Coming Days ! Here are Levels To Watch appeared first on Coinpedia - Fintech & Cryptocurreny News Media| Crypto Guide

The broader crypto market found support despite Russia’s invasion of Ukraine going into day 10. A 3-day losing streak came to an end for Bitcoin (BTC) on Saturday. Another return to sub-$39,000 levels was brief, with Bitcoin closing out at the $39,000 level for a 2nd consecutive day. At the time of writing, the global …

Cosmos was 10% lower on Saturday, as the red wave once again submerged crypto markets. Despite this, Anchor protocol was again able to extend gains, climbing by as much as 15% in the process. Cosmos (ATOM) Cosmos (ATOM) was able to hang on to the #20 spot in the crypto top 100 on Saturday, despite […]

The range-bound movement in SHIB price has dropped to the support trendline of the symmetrical triangle pattern. The buyers preparing for a bullish reversal would face a steeper trendline before challenging the pattern’s key resistance.  Key technical points:  The 200-day DMA has flipped to valid resistance The intraday trading volume in the Shiba Inu coin

The post SHIB Price Analysis: Descending Trendline Breakout Is Must To Revert Ongoing Downfall appeared first on CoinGape.

Bitcoin has fallen below $40,000 to start the weekend, as cryptocurrency markets extend recent losses. ETH was also lower on Saturday, falling to its lowest point this week in the process. Bitcoin BTC fell for its fourth consecutive session on Saturday, as the world’s largest cryptocurrency dropped below its long-term support level. The price of […]